| Identification | Back Directory | [Name]
7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl] cyclopentyl]-6-oxo-heptanoic acid | [CAS]
68324-95-8 | [Synonyms]
HFKNJQYMAGMXTR-CAPHXMBKSA-N
Δ17-6-keto Prostaglandin F1α
Prosta-13,17-dien-1-oic acid, 9,11,15-trihydroxy-6-oxo-, (9α,11α,13E,15S,17Z)-
7-[(1R,2S,3R,5S)-3,5-dihydroxy-2-[(1E,3S,5Z)-3-hydroxyocta-1,5-dienyl] cyclopentyl]-6-oxo-heptanoic acid | [Molecular Formula]
C20H32O6 | [MOL File]
68324-95-8.mol | [Molecular Weight]
368.46 |
| Chemical Properties | Back Directory | [Boiling point ]
587.067±50.00 °C(Press: 760.00 Torr)(predicted) | [density ]
1.210±0.06 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | [solubility ]
DMF: >50 mg/ml (from PGF1a); DMSO: >50 mg/ml (from PGF1a); Ethanol: >75 mg/ml (from PGF1a); PBS pH 7.2: >2.1 mg/ml (from PGF1a) | [pka]
4.688±0.10(predicted) |
| Hazard Information | Back Directory | [Uses]
Δ17-6-keto PGF1α is the non-enzymatic hydrolysis product of PGI3. PGI3 is a COX pathway metabolite of EPA in various tissues such as seminal vesicles, lung, PMNL, and ocular tissues. | [Definition]
ChEBI: Delta(17)-6-ketoprostaglandin F1alpha is a prostanoid. |
|
|